A trial of osimertinib for non small cell lung cancer (NeoADAURA)

This trial is looking at adding osimertinib to chemotherapy before surgery for non small cell lung cancer (NSCLC). It is also looking at having osimertinib on its own.

It is for people who have:

• early stage cancer or cancer that has grown into nearby tissues or lymph nodes. This is stage 2 or stage 3 NSCLC.

• changes to genes affecting a protein called EGFR